EXICURE, INC. Goodwill
EXICURE, INC. (XCUR) had Goodwill of $4.40 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2026-08-14
- 2026-06-30: Goodwill $4.40M.
- 2026-03-31: Goodwill $4.40M.
- 2025-12-31: Goodwill $4.40M.
- 2025-09-30: Goodwill $3.34M.
| Period end | Goodwill |
|---|---|
| 2026-06-30 | $4.40M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $4.40M 10-Q · filed 2026-05-29 |
| 2025-12-31 | $4.40M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $3.34M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $3.34M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $3.34M 10-Q · filed 2025-06-27 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |